News | August 20, 2007

Vital Images Releases Next-Generation Enterprise-Wide Solutions

August 21, 2007 - Vital Images announced it has released its next-generation enterprise-wide advanced visualization and analysis product solutions with the release of Vitrea 4.0 and ViTALConnect 4.1.

These releases reportedly include significant enhancements to the company's powerful cardiovascular, neurovascular and gastrointestinal applications as well as improved Web-based cardiovascular analysis and distribution capabilities.

In addition to the new version enhancements, the company also released ViTAL EP, a new electrophysiology (EP) planning application to augment its cardiovascular suite of products.
Enhancements to the company's Vitrea 4.0 workstation-client release include cardiovascular workflow enhancements such as automatic segmentation and probing of the coronary tree, easier vessel management and labeling, easy centerline editing and comprehensive reporting with automatic population of findings.
The release also includes neurovascular improvements and improved colon enhancements.

ViTAL's Web-client enhancements in the ViTALConnect 4.1 release include new cardiovascular tools, including automatic segmentation of the coronary tree, centerline editing and automatic stenosis calculation all designed to increase efficiency and productivity. Additional enhancements include improved 2D performance and integrated reporting features. The combined workstation and Web-client solution reportedly enables a streamlined workflow designed to improve efficiency.
"What I demonstrated live at the recent Stanford course - loading and analyzing a 5,020 slice study over the Web-client - I could have done from my house using my laptop," said Dr. Tony DeFrance, medical director of the CVCTA Education Center in San Francisco. "I routinely use the 'workstation-client' but it's nice to know that I can use the same powerful tools remotely using the Web-client."
The new EP planning application, ViTAL EP, contains a 3D advanced visualization and modeling tool for the EP lab. ViTAL
EP automatically segments out the pulmonary veins and creates a 3D anatomic model of the heart for super-imposed EP mapping. ViTAL EP also automatically exports a 3D model for display on the on St. Jude Medical’s EnSite System, which is used to facilitate therapy for the treatment of arrhythmias.

For more information: www.vitalimages.com.

Related Content

Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Myocarditis is an Under-recognized Etiology of Symptomatic Premature Ventricular Arrhythmia (PVCs). #HRS #HRS2018
News | EP Lab | May 18, 2018
May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have under
Novel Antibiotics Can Help Lower EP Device Infection Rates. Pictured here is an ICD. Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

News | EP Lab | May 17, 2018
May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics
The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT). #HRS2018

The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT).  

News | EP Lab | May 16, 2018
May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced
LivaNova Completes Sale of Cardiac Rhythm Management (CRM - electrophysiology) Business to MicroPort Scientific
News | EP Lab | April 30, 2018
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPor
LivaNova Enters Binding Letter of Intent to Sell Cardiac Rhythm Management Business
News | EP Lab | January 26, 2018
January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp.
Societies Detail Treatment for Patients With Ventricular Arrhythmias
News | EP Lab | October 30, 2017
The American College of Cardiology, along with the American Heart Association and the Heart Rhythm Society, published...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab | October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Overlay Init